NCT00453310View on ClinicalTrials.gov

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Extragonadal Germ Cell TumorOvarian CancerTeratomaTesticular Germ Cell Tumor
Interventions
DRUG

sunitinib malate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Pfizer

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER